Adverse drug reactions in pregnant women;Effets indésirables des médicaments chez la femme enceinte

Therapie

Volumn 62, Issue 5, 2007, Pages 455-460

  Lacroix, Isabelle ^a,b   Cabou, Cendrine ^a   Montastruc, Jean Louis ^a   Damase Michel, Christine ^a  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Adverse drug reaction (ADR); Anaphylactic reaction; Pregnancy

Indexed keywords

BETAMETHASONE; CALCIUM CARBONATE; CARDIOVASCULAR AGENT; DEXTRAN; INDOMETACIN; METRONIDAZOLE; MIFEPRISTONE; NEOMYCIN; NICARDIPINE; NIFEDIPINE; NYSTATIN; OXYTOCIN; PHLOROGLUCINOL; PREDNISOLONE; RITODRINE; SALBUTAMOL;

ADULT; ANAPHYLAXIS; ARTICLE; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; FEMALE; FRANCE; HUMAN; HYDRAMNIOS; HYPOTENSION; INCIDENCE; MAJOR CLINICAL STUDY; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR; STILLBIRTH; TACHYCARDIA; THIRD TRIMESTER PREGNANCY;

EID: 39749100128     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: 10.2515/therapie:2007067     Document Type: Article

References (25)

1. Little BB. Pharmacokinetic during pregnancy : evidence-based maternal dose formulation. Obstet Gynecol 1999; 93: 858-68
2. Ward RM. Pharmacological treatment of the fetus. Clinical pharmacokinetic considerations. Clin Pharmacokinet 1995; 28(5): 343-50
3. Scott LD. Gastrointestinal disease in pregnancy. IN: Creasy RK, Resnick R, editors. Maternal-fetal medicine : principle and practice. Philadelphia : WB Saunders, 1994 : 1026-39
4. O'sullivan GM, Sutton AJ, Thompson SA, et al. Noninvasive measurement of gastric emptying in obstetric patient. Anesth Analg 1987; 66: 505-11
5. Pritchard JA. Changes in the blood volume during pregnancy and delivery. Anesthesiology 1965; 26: 393-9
6. Lund CJ, Donovan JC. Blood volume during pregnancy. Am J Obstet Gynecol 1967; 98: 393-401
7. Mattison DR, Malek A, Cistola C. Physiologic adaptations to pregnancy : impact on pharmacokinetics. In: Yaffe SJ, Aranda JV, eds. Pediatric Pharmacology: Therapeutic principles in practice. Philadelphia: WB Saunders, 1992: 81-96
8. Berg MJ. Status of research on gender differences. J Am Pharm Assoc 1997; 37: 43-56
9. AMon I, Hüller H. Drug metabolism in pregnant women. In: Kuemmerle HP, Brendel K, eds. Clinical pharmacology in pregnancy: Fundamentals and rational pharmacotherapy. New York: Thieme-Stratton, 1984 : 74-86
10. Bacq Y, Zarka O, Brechot J-F, et al. Liver function tests in normal pregnancy : a prospective study of 103 pregnant women and 103 matched controls. Hepatology 1996; 23: 1030-4
11. Bacq Y. Hépatopathies au cours de la grossesse. Gastroenterol Clin Biol 2001; 25: 791-8
12. Davison JM, Dunlop W. Changes in renal hemodynamics and tubular function induced by normal human pregnancy. Semin Nephrol 1984; 4: 198-207
13. Dunlop W. Serial changes in renal hemodynamics during normal human pregnancy. Br J Obstet Gynaecol 1981; 88: 1-9
14. Larsen B, Glover DD. Serum erythromycin levels in pregnancy. Clin Ther 1998; 20: 971-7
15. Atteintes hépatiques sous Utrogestran® pendant la grossesse. Rev Prescr 1999; 193: 202-3
16. Thompson CA. Antiretroviral combination may put pregnant women at risk of fatal lactic acidosis. Am J Health Syst Pharm 2001; 58: 291 [letter]
17. Begaud B, Evreux JC, Jouglard J, et al. Imputabilité des effets inattendus ou toxiques des médicaments. Therapie 1985; 40: 111-8
18. Montastruc P, Damase-Michel C, Lapeyre-Mestre M, et al. A prospective intensive study of adverse drug reactions in Urban General Practice. Clin Drug Invest 1995; 10: 117-22
19. Horen B, Montastruc JL, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol 2002; 54: 665-70
20. Di-Meglio JL, Lacroix I, Bourrel R, et al. PRescription of psychoactive drugs during pregnancy in France. Fund Clin Pharmacol 2005; 19: 224 [ABSTRACT]
21. Lacroix I, Damase-Michel C, Lapeyre-Mestre M, et al. Prescription of drugs during pregnancy in France. Lancet 2000; 356: 1735-6
22. Walters BN, Redman CW. Treatment of severe pregnancy-associated hypertension with the calcium antagonist nifedipine. Br J Obstet Gynaecol 1984; 91: 330-6
23. Tsatsaris V, Papatsonis D, Goffinet F, et al. Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis. Obstretrics and Gynecology 2001; 5: 840-7
24. Berg EM, Fasting S, Sellevold OF. Serious complications with dextran-70 despite hapten prophylaxis. Is it best avoided prior to delivery? Anesthesia, 1991; 46: 1033-5
25. Rosay H, Lancon JP, Ferrut O, Gisselmann E, et al. An anaphylactic-type accident caused by a dextran solution in a parturient. Cah Anesthesiol; 1989, 37: 541-2